Literature DB >> 32601794

Cord blood serum harvesting by hydroxyethyl starch: a fetal bovine serum alternative in expansion of umbilical cord-derived mesenchymal stem cells.

Maryam Samareh Salavati Pour1,2,3, Reza Vahidi4,5, Mahla Lashkari2,3, Ali Derakhshani6,2, Zahra Ameri2,3, Alireza Farsinejad7,8.   

Abstract

As a widely used cell culture supplement, fetal bovine serum (FBS) harbor high content of growth, proliferation, and adhesion factors. However, high cost, bio-safety, possible xenogeneic agent transmission, finite accessible, and ethical controversy are major obstacles that discourage the use of this additive. Accordingly, novel alternatives have been proposed with various pros and cons. Still, caution should be taken in choosing suitable substitute given that the alteration in the main aspects of cultured cells can be biased the consequences of clinical applications. Herein, the authors evaluated the impact of cord blood serum harvesting by hydroxyethyl starch (CBS-HES), as an enriched source of growth factors, on the basic mesenchymal stem cells (MSCs) characteristics. In the present experiment, umbilical cord-derived MSCs were isolated and continuously nourished with Dulbecco's Modified Eagle Medium containing either 10, 15, and 20% CBS-HES or FBSs to compare their morphology, immunophenotype, growth and proliferation rate, death rate, cell cycle, and gene expression profiles. Although all enriched media supported the expansion of MSCs with comparable morphology, cell surface markers, death rate, c-MYC and p16 expression, and growth rate, CBS-HES treated cells significantly (P < 0.05) expressed more hTERT gene in a concentration-dependent manner. Yet no significant shift was observed in the cell cycle of cultured cells using the same concentrations of additives, a finding which further confirmed by Ki-67 immunostaining. CBS-HES as an available and affordable additive, seems to be an optimal, relatively safe, and promising FBS alternative for cultivation, propagation, and subsequent clinical applications of MSCs.

Entities:  

Keywords:  FBS alternative; Fetal bovine serum; Hydroxyethyl starch; Mesenchymal stem cells; Umbilical cord

Year:  2020        PMID: 32601794      PMCID: PMC7450036          DOI: 10.1007/s10616-020-00404-9

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  35 in total

1.  Human Umbilical Cord Blood Serum/Plasma: Cytokine Profile and Prospective Application in Regenerative Medicine.

Authors:  Yu A Romanov; V V Vtorushina; T N Dugina; A Yu Romanov; N V Petrova
Journal:  Bull Exp Biol Med       Date:  2019-11-25       Impact factor: 0.804

Review 2.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

3.  Human Umbilical Cord Blood Serum: Effective Substitute of Fetal Bovine Serum for Culturing of Human Multipotent Mesenchymal Stromal Cells.

Authors:  Yu A Romanov; E E Balashova; N E Volgina; N V Kabaeva; T N Dugina; G T Sukhikh
Journal:  Bull Exp Biol Med       Date:  2017-02-27       Impact factor: 0.804

4.  Autologous plasma rich in growth factors technology for isolation and ex vivo expansion of human dental pulp stem cells for clinical translation.

Authors:  Eduardo Anitua; Mar Zalduendo; María Troya
Journal:  Regen Med       Date:  2019-02-15       Impact factor: 3.806

5.  Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.

Authors:  Barbara J Bryant; Yu Ying Yau; Phyllis J Byrne; David F Stroncek; Susan F Leitman
Journal:  Transfusion       Date:  2010-01-22       Impact factor: 3.157

6.  A Simple Method to Isolate and Expand Human Umbilical Cord Derived Mesenchymal Stem Cells: Using Explant Method and Umbilical Cord Blood Serum.

Authors:  Ghmkin Hassan; Issam Kasem; Chadi Soukkarieh; Majd Aljamali
Journal:  Int J Stem Cells       Date:  2017-11-30       Impact factor: 2.500

7.  Umbilical Cord Blood Platelet Lysate as Serum Substitute in Expansion of Human Mesenchymal Stem Cells.

Authors:  Negin Shirzad; Sima Bordbar; Monire Mohammad; Alireza Goodarzi; Pardis Khosravani; Froughazam Sayahpour; Mohamadreza Baghaban Eslaminejad; Marzieh Ebrahimi
Journal:  Cell J       Date:  2017-08-19       Impact factor: 2.479

8.  Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs.

Authors:  Sangeetha Kandoi; Praveen Kumar L; Bamadeb Patra; Prasanna Vidyasekar; Divya Sivanesan; Vijayalakshmi S; Rajagopal K; Rama Shanker Verma
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

9.  Comparative study of the effects of fetal bovine serum versus horse serum on growth and differentiation of primary equine bronchial fibroblasts.

Authors:  Jana Franke; Vanessa Abs; Claudia Zizzadoro; Getu Abraham
Journal:  BMC Vet Res       Date:  2014-05-26       Impact factor: 2.741

10.  Human Umbilical Cord Blood-Derived Serum for Culturing the Supportive Feeder Cells of Human Pluripotent Stem Cell Lines.

Authors:  Ruttachuk Rungsiwiwut; Praewphan Ingrungruanglert; Pranee Numchaisrika; Pramuan Virutamasen; Tatsanee Phermthai; Kamthorn Pruksananonda
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

View more
  2 in total

Review 1.  Regenerative Therapy Using Umbilical Cord Serum.

Authors:  Nagarajan Maharajan; Gwang-Won Cho; Ji Hyun Choi; Chul Ho Jang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

2.  Elevated Bax/Bcl-2 Ratio: A Cytotoxic Mode of Action of Kermanian Propolis Against an Acute Lymphoblastic Leukemia Cell Line, NALM-6.

Authors:  Moghadari Masoud; Samareh Salavati Pour Maryam; Sattarzadeh Bardsiri Mahla; Kouhbananinejad Seyedeh Mehrnaz; Lashkari Mahla; Vahidi Reza; Kashani Bahareh; Dehesh Tania; Farsinejad Alireza
Journal:  Indian J Hematol Blood Transfus       Date:  2022-01-31       Impact factor: 0.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.